RETRACTED: Melatonin Mediates Osteoblast Proliferation Through the STIM1/ORAI1 Pathway

Lili Cao, Keda Yang, Wei Yuan, Siming Zhou, Rui Zhao, Shui Qiu

Open source

DOI
10.3389/fphar.2022.851663
Published
2022-03-22
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2022.851663,
  title = {RETRACTED: Melatonin Mediates Osteoblast Proliferation Through the STIM1/ORAI1 Pathway},
  author = {Lili Cao and Keda Yang and Wei Yuan and Siming Zhou and Rui Zhao and Shui Qiu},
  year = {2022},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2022.851663},
  url = {https://doi.org/10.3389/fphar.2022.851663}
}

RIS

TY  - JOUR
TI  - RETRACTED: Melatonin Mediates Osteoblast Proliferation Through the STIM1/ORAI1 Pathway
AU  - Lili Cao
AU  - Keda Yang
AU  - Wei Yuan
AU  - Siming Zhou
AU  - Rui Zhao
AU  - Shui Qiu
PY  - 2022
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2022.851663
UR  - https://doi.org/10.3389/fphar.2022.851663
ER  - 

APA

Cao, L., Yang, K., Yuan, W., Zhou, S., Zhao, R., & Qiu, S. (2022). RETRACTED: Melatonin Mediates Osteoblast Proliferation Through the STIM1/ORAI1 Pathway. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2022.851663

Source records